PharmiWeb.com - Global Pharma News & Resources
29-Jun-2022

PHASTAR Names Chris Schoonmaker as Chief Operations Officer

PHASTAR Names Chris Schoonmaker as Chief Operations Officer

London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience. 

Andrew MacGarvey, PHASTAR’s Chief Executive Officer said “I am delighted to welcome Chris to the team. His experience running global operations coupled with his reputation for excellent customer service will be invaluable as we continue to scale the business. He is joining a fantastic management team and will help us execute against our mission to be the provider of choice for biometrics services around the world, and to be the employer of choice for biometrics professionals."

Chris has worked in the clinical trial and health care space for over 25 years and has held several senior leadership roles, including oversight of biometric operations as well as managing customer relationships related to strategic accounts. The majority of his career has been with CROs, where he has developed effective operational strategies coinciding with business growth. Throughout his career, Chris has been a statistical lead for hundreds of clinical studies, served as a voting member on data monitoring committees, provided statistical consultation, and guided the statistical strategy for dozens of regulatory submissions. Chris received his Master of Public Health in Epidemiology and Biostatics from Boston University.

-END-

 

About PHASTAR

PHASTAR is a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting, and clinical trial reporting services by providing expert consultants and managing and delivering in-house projects, FSP style arrangements and preferred partnerships. PHASTAR currently has over staff across 14 offices (United States, United Kingdom, Australia, Germany, Kenya, Japan, India, and China) with plans to open additional locations in the future to serve prospective and existing clients. PHASTAR’s number one priority is to ensure that the work produced is of the highest quality. Every project PHASTAR undertakes utilizes unique internal processes which are designed to ensure optimal quality.

All PHASTAR’s data management, data science statistical and programming, staff are trained in the “PHASTAR Discipline” - an in-house approach to data analysis and collection. This comprises a set of common sense (but commonly ignored) principles that, if followed, guarantee error free outcomes. The “PHASTAR Discipline” also includes a series of intranet-based checklists highlighting potential pitfalls and points-to-consider when conducting clinical trials, enabling over 4,000 years of combined technical knowledge to be shared across the company.

For further information on PHASTAR contact tellmemore@phastar.com

 

Media Contact 

Jodie Dixon - Discovery PR, on behalf of PHASTAR 

Email: Jodie@discovery-pr.com   

Mobile: + 44 (0) 7852 153 791    Office:   +44 (0) 1606 889 194   

Editor Details

Related Links

Last Updated: 05-Jul-2022